Effects of recombinant growth hormone (GH) treatment on bone mineral density and body composition in adults with childhood onset growth hormone deficiency

Journal of Endocrinological Investigation

Volumn 19, Issue 8, 1996, Pages 524-529

  Sartorio, A ^a,b   Ortolani, S ^a   Conti, A ^a,b   Cherubini, R ^a   Galbiati, E ^a   Faglia, G ^b  

^a ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Adulthood; Body composition; Bone density; GH; GH deficiency

Indexed keywords

HUMAN GROWTH HORMONE; RECOMBINANT GROWTH HORMONE;

ADULT; ARTICLE; BODY COMPOSITION; BODY FAT; BONE DENSITY; BONE MINERAL; CARPAL TUNNEL SYNDROME; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMUR; GROWTH HORMONE DEFICIENCY; HIP; HUMAN; LEAN BODY WEIGHT; LIMB; LUMBAR SPINE; MALE; NORMAL HUMAN; SOFT TISSUE; SUBCUTANEOUS DRUG ADMINISTRATION; TRUNK;

EID: 0029803631     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03349011     Document Type: Article

References (33)

1. Brixen K., Nielsen H.K., Mosekilde L., Flyvbjerg A. A short course of recombinant human growth hormone treatment stimulates osteoblasts and activates bone remodeling in normal human volunteers. J. Bone Miner. Res. 5: 609, 1990.
2. Brixen K., Kassem M., Eriksen E.F., Nielsen H.K., Flyvbjerg A., Mosekilde L. Growth hormone (GH) and adult bone remodeling: the potential use of GH in the treatment of osteoporosis. J. Pediatr. Endocrinol. 6: 65, 1993.
3. Ferrandez A., Zachmann M., Prader A., Illig R. Isolated growth hormone deficiency in prepubertal children: influence of human growth hormone on longitudinal growth, adipose tissue, bone mass and bone maturation. Helv. Paediatr. Acta 6: 566, 1970.
4. Shore R.M., Chesney R.W., Mazees R.B., Rose P.G.F., Bargman G.J. Bone mineral status in growth hormone deficiency. J. Pediatr. 96: 393, 1980.
5. Kaufman J.M., Taelman P., Vermeulen A., Vandeweghe M. Bone mineral status in growth hormone deficient males with isolated and multiple pituitary deficiencies of childhood onset. J. Clin. Endocrinol. Metab. 74: 118, 1992.
6. Rosen T., Hansson T., Granhed H., Szucs J., Bengtsson B.A. Reduced bone mineral content in adult patients with growth hormone deficiency. Acta Endocrinol. (Copenh.) 129: 201, 1993.
7. Sartorio A., Conti A., Monzani M. New markers of bone and collagen turnover in children and adults with growth hormone deficiency. Postgrad. Med. J. 69: 846, 1993.
8. Sartorio A., Conti A., Monzani M., Morabito F., Faglia G. Growth hormone treatment in adults with GH deficiency: effects on new biochemical markers of bone and collagen turnover. J. Endocrinol. Invest. 13: 893, 1993.
9. Degerblad M., Elgindy N., Hall K., Sjoberg H.E., Thoren M. Potent effect of recombinant growth hormone on bone mineral density and body composition in adults with panhypopituitarism. Acta Endocrinol. (Copenh.) 126: 387, 1992.
10. Salomon F., Cuneo R.C., Hesp R., Sonksen P.H. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N. Engl. J. Med. 321: 1797, 1989.
11. Jorgensen J.O.L., Pedersen S.A., Thuesen L., Jorgensen J., Ingemann-Hansen T., Skakkebaek N.B., Christiansen J.S. Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet i: 1221, 1989.
12. Elgindy N., Grunditz R., Thoren M., Degerblad M., Sjoberg H.E., Ringertz H. Long term follow-up of metacarpal cortical thickness and bone mineral density in panhypopituitarism. Radiol. Diagn. 32: 326, 1991.
13. O'Halloran D.J., Tsatsoulis A., Whitehouse B.W., Holmes S.J., Adams J.E., Shalet S.M. Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated GH deficiency. J. Clin. Endocrinol. Metab. 76: 1344, 1993.
14. Holmes S.J., Whitehouse R.W., Economou G., O'Halloran D.J., Adams J.E., Shalet S.M. Further increase in forearm cortical bone mineral content after discontinuation of growth hormone replacement. Clin. Endocrinol. (Oxf.) 42: 3, 1995.
15. Van Der Veen E.A., Netelembos J.C. Growth hormone (replacement) therapy in adults: bone and calcium metabolism. Horm. Res. 33 (suppl 4): 65, 1990.
16. Orme S.M., Sebastian J.P., Oldroyd B., Steward S.P., Grant P.J., Stickland M.H., Smith M.A., Belchetz P.E. Comparison of measures of body composition in a trial of low dose growth hormone replacement therapy. Clin. Endocrinol. (Oxf.) 37: 453, 1992.
17. Whitehead H.M., Boreham C., Mcilrath E.M., Sheridan B., Kennedy L., Atkinson A.B., Hadden D.R. Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study. Clin. Endocrinol. (Oxf.) 36: 45, 1992.
18. Binnerts A., Swart G.R., Wilson J.H.P., Hoogerbrugge N., Pols H.A.P, Birkenhager J.C., Lambers S.W.J. The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition. Clin. Endocrinol. (Oxf.) 37: 79, 1992.
19. Bengtsson B.A., Eden S., Lonn L., Kvist H., Stokland A., Lindstedt G., Bosaeus I., Tolli J., Sjostrom L., Isaksson O.G.P. Treatment of adults with growth hormone deficiency with recombinant human growth hormone. J. Clin. Endocrinol. Metab. 76: 309, 1993.
20. Beshyah S.A., Freemantle C., Shahi M., Anyaoku V., Merson S., Lynch S., Skinner E., Sharp P., Foale R., Johnston D.G. Replacement treatment with biosynthetic human growth hormone in growth hormone-deficient hypopituitary adults. Clin. Endocrinol. (Oxf.) 42: 73, 1995.
21. Mazess R.B., Barden H.S., Bisek J.P., Hanson J. Dual- energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition. Am. J. Clin. Nutr. 51: 1106, 1990.
22. Gandolini G.G., Trevisan C., Berino F., Krogh V., Sibilla P., Rainero G., Ortolani S. Fat and lean body mass measured by DXA: short-term precision and comparison with anthropometric parameters. In: First International Symposium on "Osteoporosis and metabolic bone diseases", International Academic Publishers (ed.), Bejing, 1992, p. 31.
23. Barnard R., Ng K.W., Martin T.J., Waters M.J. Growth hormone (GH) receptors in clonal osteoblast-like cells mediate a mitogenic response to GH. Endocrinology 128: 1459, 1991.
24. Ernst M., Froesch E.R. Growth hormone dependent stimulation of osteoblast-like cells in serum free cultures via local synthesis of insulin-like growth factor I. Biochem. Biophys. Res. Commun. 151: 142, 1988.
25. Marcus R., Butterfield G., Holloway L., Gilliland L., Baylink D.J., Hintz R.L., Sherman B.M. Effects of short term administration of recombinant human growth hormone to elderly people. J. Clin. Endocrinol. Metab. 70: 519, 1990.
26. Zamboni G., Antoniazzi F., Radetti G., Musumeci C., Tatò L. Effects of two different regimens of recombinant human growth hormone therapy on the bone mineral density of patients with growth hormone deficiency. J. Pediatr. 119: 483, 1991.
27. Holmes S.J., Economou G., Whitehouse R.W., Adams J.E., Shalet S.M. Reduced bone mineral density in patients with adult onset growth hormone deficiency. J. Clin. Endocrinol. Metab. 78: 669, 1994.
28. Bergmann P., Valsamis J., Van Perborgh J., De Schepper J., Van Vliet G. Comparative study of the changes in insulin-like growth factor-I, procollagen-III-N-terminal extension peptide, bone Gla-protein, and bone mineral content in children with Turner's syndrome treated with recombinant growth hormone. J. Clin. Endocrinol. Metab. 71: 1461, 1990.
29. Johansson A.G., Lindh E., Ljunghall S. IGFs: function and clinical importance. Growth hormone, insulin-like growth factor I, and bone: a clinical review. J. Intern. Med. 234: 553, 1993.
30. Vandeweghe M., Taelman P., Kaufman J.M. Short and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males. Clin. Endocrinol. (Oxf.) 39: 409, 1993.
31. Rutherford O.M., Jones D.A., Round J.M., Buchanan C.R., Preece M.A. Changes in skeletal muscle and body composition after discontinuation of growth hormone treatment in growth hormone deficient young adults. Clin. Endocrinol. (Oxf.) 34: 469, 1991.
32. Rosen T., Bengtsson B.A. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet i: 285, 1990.
33. Sartorio A., Narici M. Growth hormone (GH) treatment in GH-deficient adults: effects on muscle size, strength and neural activation. Clin. Physiol. 14: 527, 1994.